Treatment of achondroplasia with growth hormone: Six years of experience

Pediatric Research

Volumn 46, Issue 4, 1999, Pages 435-439

  Ramaswami, U ^a   Rumsby, G ^b   Spoudeas, H A ^a   Hindmarsh, P C ^a   Brook, C G D ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HUMAN GROWTH HORMONE;

ACHONDROPLASIA; ARTICLE; BODY GROWTH; BONE GROWTH; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032822419     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199910000-00012     Document Type: Article

References (34)

1. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A 1994 Mutations in the gene encoding fibroblast growth factor receptor 3 in achondroplasia. Nature 371:252-254
2. Bellus G, Hefferon TW, Ortiz de Luna R, Hecht JT, Horton WA, Machado M, Kaitila I, McIntosh I, Francomano C 1995 Achondroplasia is denned by recurrent G380R mutations of FGFR3. Am J Hum Genet 56:368-373
3. Webster M, Donoghue DJ 1996 Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 15:520-527
4. Wilkie AO, Morris-Kay GM, Jones EY, Heath JK 1995 Function of fibroblast growth factors and their receptors. Curr Biol 5:500-507
5. Ikegawa S, Fukushima Y, Isomura M, Takada F, Nakamura Y 1995 Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet 96:309-311
6. Wynne-Davies R, Walsh WK, Gormley J 1981 Achondroplasia and hypochondroplasia. Clinical variation and spinal stenosis. J Bone Joint Surg 63:508-515
7. Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG 1978 Standard growth curves for achondroplasia. J Pediatr 93:435-438
8. Hunziker EB, Wagner J, Zapf J 1994 Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 93:1078-1086
9. Rimoin D, Hughes G, Kawfman RL, Rosenthal RE, McAlister WH, Silberberg R 1970 Endochondral ossification in achondroplastic dwarfism. N Engl J Med 283:728-735
10. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J 1988 Action of growth hormone: current views. Acta Paediatr (suppl)343:12-18
11. Daughaday WH, Hall K, Raben MS, Salmon Jr WD, Van den Brande JL, Van Wyk JJ 1972 Somatomedin: proposed designation factor for sulphation factor. Nature 235:107
12. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrin Rev 8:426-438
13. Green H, Morikawa M, Nixon T 1985 A dual effector theory of growth hormone action. Differentiation 29:195-198
14. Zadik Z, Landau H, Chen M, Aitman Y, Lieberman E 1992 Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM 9 cells, and GH response to pharmacological stimulation. J Clin Endocrinol Metab 75:412-416
15. Hindmarsh PC, Bridges NA, Brook CGD 1991 Wider indications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol 34:417-427
16. Bridges NA, Brook CGD 1994 Progress report: growth hormone in skeletal dysplasia. Horm Res 42:231-234
17. Horton WA, Hecht JT, Hood OJ, Marshall RN, Moore WV, Hollowell JG 1992 Growth hormone therapy in achondroplasia. Am J Med Genet 42:667-670
18. Nishi Y, Kajiyama M, Miyagawa S, Fujiwara M, Hamamoto K 1993 Growth hormone therapy in achondroplasia. Acta Endocrinol 128:394-396
19. Weber G, Prinster C, Meneghel M, Russo F, Mora S, Puzzovio M, Del Maschio M, Chiumello G 1996 Human growth hormone treatment in prepubertal children with achondroplasia. Am J Med Genet 61:396-400
20. Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL 1996 Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia. J Clin Endocrinol Metab 81:4033-4037
21. Tanaka H, Kubo T, Yamate T, Ono T, Kanzaki S, Seino Y 1998 Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype. Eur J Endocrinol 138:275-280
22. Oberklaid F, Dances DM, Jennies F, Stacie L, Rosshandler S 1979 Achondroplasia and hypochondroplasia. J Med Genet 16:140-146
23. Ehrlich H 1989 PCR Technologies. Cold Spring Harbour, NY, pp 35-36
24. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342
25. Tanner JM, Whitehouse RH, Takaishi M 1966 Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children. 1966. Part II. Arch Dis Child 41:613-635
26. Tanner JM 1962 Growth at Adolescence. Blackwell Scientific Publications, Oxford
27. Cox LA 1996 Tanner-Whitehouse method of assessing skeletal maturity: problems and common errors. Horm Res 45(suppl 2):53-55
28. Cleveland WS 1979 Robust locally weighted regression smoothing scatter plots. J Am Stat Assoc 74:829-836
29. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Cara JF, Chernausek S, Gotlin RAW, Chintz J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ 1998 Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132:319-324
30. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ 1996 Does growth hormone affect adult height in Turner's syndrome? Lancet 348:25-27
31. Breunen G, Cameron N 1980 The reproducibility of TW2 skeletal age assessments by a self-taught assessor. Ann Hum Biol 7:155-162
32. Lyon AJ, Preece MA, Grant DB 1985 Growth curve for girls with Turner's syndrome. Arch Dis Child 60:932-935
33. Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA 1995 Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24
34. Darendeliler F, Hindmarsh PC, Brook CG 1990 Dose-response curves for treatment with biosynthetic human growth hormone. J Endocrinol 125:311-316